Yu, X., Munoz-Sagredo, L., Streule, K., Muschong, P., Bayer, E., Walter, R. J., . . . Orian-Rousseau, V. (2021). CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues. Blood, 138(12), . https://doi.org/10.1182/blood.2020006343
Chicago-Zitierstil (17. Ausg.)Yu, Xiaobing, et al. "CD44 Loss of Function Sensitizes AML Cells to the BCL-2 Inhibitor Venetoclax by Decreasing CXCL12-driven Survival Cues." Blood 138, no. 12 (2021). https://doi.org/10.1182/blood.2020006343.
MLA-Zitierstil (9. Ausg.)Yu, Xiaobing, et al. "CD44 Loss of Function Sensitizes AML Cells to the BCL-2 Inhibitor Venetoclax by Decreasing CXCL12-driven Survival Cues." Blood, vol. 138, no. 12, 2021, https://doi.org/10.1182/blood.2020006343.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.